COR - NEW YORK STOCK EXCHANGE, INC.
Industry: Health Care
Market Cap: 54.9 B
IPO Date: May 28, 1996
Country: US
Currency: USD
Shares Outstanding: 193.7 M
5/11/2025
The fund lagged its benchmark in Q1. Strong stock selection in materials, real estate and health care was offset by weakness in IT and industrials.
Source: SeekingAlpha
5/10/2025
See here for weekly updates on Dividend Champions, Contenders & Challengers. Find dividend changes, ex-dividend dates & payment schedules.
Source: SeekingAlpha
5/9/2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Source: Yahoo
5/8/2025
Cencora Inc. stock underperforms Thursday when compared to competitors
Source: MarketWatch
5/8/2025
The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.
Source: SeekingAlpha
5/8/2025
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Source: Yahoo
5/7/2025
Cencora (NYSE:COR) announced a notable 15% price increase over the last quarter, which coincided with substantial financial improvements as reported in its latest earnings release. The company reported growth in both sales and income, with second-quarter sales rising to $75.5 billion and net income increasing to $718 million, highlighting a strong performance compared to last year. Alongside this, the declaration of a quarterly cash dividend of $0.55 per common share likely reinforced...
Source: Yahoo
5/7/2025
Cencora Inc. stock outperforms competitors on strong trading day
Source: MarketWatch
5/7/2025
Cencora, Inc. (NYSE:COR) Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ETCompany ParticipantsBennett Murphy - Senior Vice President, Head of Investor...
Source: SeekingAlpha
5/7/2025
CONSHOHOCKEN, Pa., May 07, 2025--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year to $75.5 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.68 for the second quarter of fiscal 2025 compared to $2.09 in the prior year second quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below, in
Source: Yahoo
5/7/2025
The following slide deck was published by Cencora, Inc.
Source: SeekingAlpha
5/7/2025
Cencora Lifts View on Weight-Loss Drug Demand as Profit Surges
Source: MarketWatch
5/7/2025
U.S. drug distributor Cencora raised its annual profitforecast on Wednesday, driven by robust demand for costly specialty medicines and weight-lossdrugs. The company now expects its...
Source: Finnhub
5/7/2025
Cencora, Inc. Second Quarter Fiscal 2025 Earnings Call May 7, 2025 ...
Source: Finnhub
5/7/2025
Exhibit 99.1 CENCORA REPORTS FISCAL 2025 SECOND QUARTER...
Source: Finnhub
5/7/2025
Cencora, Inc. reported earnings results for the second quarter and six months ended March 31, 2025. For the second quarter, the company reported sales was USD 75,453.67 million compared to USD...
Source: Finnhub
5/7/2025
The Board of Directors of Cencora, Inc. declared a quarterly cash dividend of $0.55 per common share, payable June 2, 2025, to stockholders of record at the close of business on May 16, 2025....
Source: Finnhub
5/2/2025
April was a volatile month, and we took full advantage of the opportunities this presented. Click here to read the full letter.
Source: SeekingAlpha
4/30/2025
Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Source: Yahoo
4/30/2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Source: Yahoo